Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study

Overview of attention for article published in Pediatric Rheumatology, September 2011

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

N Ruperto1*, H Brunner2, G Horneff1, P Quartier1, T Constantin1, Y Berkun1, M Erguven1, T Kallinich1, R Brik1, NM …

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.